Project

Abbvie UPHOLD P20-095 SLEERA

Automatically Closed ยท 2020 until 2023

Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Automatically Closed
Start Date
2020
End Date
2023
Financing
Others
Brief description/objective

Upadacitinib treatment patterns, achievement of treatment targets and maintenance of response in moderate to severe Rheumatoid Arthritis patients in real-world practice